Sinovac Biotech Co., Ltd: Hand, Foot and Mouth Disease trials

The registry lists 20 Hand, Foot and Mouth Disease studies with Sinovac Biotech Co., Ltd as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 2Phase 3 5Phase 4 6No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Bridging Clinical Trial of EV71 Vaccine in Vietnamese ChildrenNot yet recruitingNCT07793175Not applicable
• Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).Not yet recruitingNCT07611513Phase 3
• Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)RecruitingNCT06734832Phase 3
• Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in IndonesiaNot yet recruitingNCT06251219
• Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).CompletedNCT06754384Phase 1/2
• Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical TrialCompletedNCT06063057Phase 1/2
• A Serosurvey Study of Hand, Foot, and Mouth Disease in IndonesiaCompletedNCT05637229
• An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)Status unknownNCT05397587Phase 4
• Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in ShanghaiStatus unknownNCT05166044
• Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization VaccinesCompletedNCT04111432Phase 4
• Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 MonthsCompletedNCT03909074Phase 3
• Efficacy Trial of a Commercial EV71 VaccineCompletedNCT03903926Phase 4
• Immunogenicity and Safety of Two Different Commercial EV71 VaccinesCompletedNCT03873740Phase 4
• Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT03281174
• Phase IV Clinical Trial, Immunogenicity and Safety of EV71 VaccineCompletedNCT03278132Phase 4
• Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI VaccinesCompletedNCT03274102Phase 4
• A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT02001233
• Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01636245Phase 3
• An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01507857Phase 3
• Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy ChildrenCompletedNCT01273246Phase 1